Academic Journal
Q1Journal of Antimicrobial Chemotherapy
About Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy is a scholarly journal published by Oxford University Press. SCImago 2025 places it in Q1 with an SJR of 1.258 and an H-index of 236.
Its listed coverage is 1975-2026 and its research categories include Infectious Diseases (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). The 2025 dataset reports 487 documents and 4972 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Pneumonia and Respiratory Infections, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing.
Recent Research Articles
Latest publications matched automatically by ISSN.
Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide
Philippe Poirier, Maxime Moniot, Virginie Bonnin, Gaëlle Castan et al.
2026-09-01 · DOI: 10.1093/jac/dkag319Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study
Abiu Sempere, Lorena de la Mora, Alexy Inciarte, Leire Berrocal et al.
2026-09-01 · DOI: 10.1093/jac/dkag297First virological control after >30 years of antiretroviral therapy in extensively drug-resistant HIV: potential role of lenacapavir plus ibalizumab
Dario Diana, Tommaso Clemente, Diana Canetti, Giovanni Festa et al.
2026-09-01 · DOI: 10.1093/jac/dkag316Tigecycline-resistant Staphylococcus in waiting pens of a pig slaughterhouse: genomic insights into a food safety alert
Honghao Huang, Feifei Zhao, Ruonan Zhao, Lu Diao et al.
2026-09-01 · DOI: 10.1093/jac/dkag254Use of fomepizole as a novel approach for preventing aciclovir-induced neurotoxicity
Åse Östholm, Erik Lindeman, Ylva Böttiger, Dan Eklund et al.
2026-09-01 · DOI: 10.1093/jac/dkag313Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose–response study
Sung-Ching Pan, Ming-Tao Tsai, Jann-Tay Wang, Wang-Huei Sheng et al.
2026-09-01 · DOI: 10.1093/jac/dkag322A multinational genomic framework for predicting β-lactam resistance in Haemophilus influenzae
Ala-Eddine Deghmane, Maria Asmi, Sören Abel, Paula Bajanca-Lavado et al.
2026-09-01 · DOI: 10.1093/jac/dkag307Implementation, adoption and impact of clinical decision support system for antibiotic prescribing in primary care: a systematic review
Racha Ibrahim, Claire Durand, Monsey Macleod, François-Xavier Lescure et al.
2026-09-01 · DOI: 10.1093/jac/dkag276Comment on: ‘Clinical outcomes of beta lactam monotherapy versus beta-lactam plus azithromycin in hospitalized patients with community-acquired pneumoniae’
Evangelos J Giamarellos-Bourboulis, Michael S Niederman
2026-09-01 · DOI: 10.1093/jac/dkag302Assessment of Enterococcus faecalis biofilm response to amoxicillin and ciprofloxacin using a dynamic in vitro pharmacokinetic–pharmacodynamic model of catheter-associated urinary tract infection
Desiye Tesfaye Tegegne, Paweł Jajor, Jacek Bania, Paweł Migdał et al.
2026-09-01 · DOI: 10.1093/jac/dkag311In-hospital antibiotic consumption in Lombardy, Italy (2017–2024): a retrospective analysis of regional administrative data
Matteo Augello, Massimo Cartabia, Marina Azab, Camilla Tincati et al.
2026-09-01 · DOI: 10.1093/jac/dkag314BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole
Pierre Delique, Christian Kemmer, Lisa Husband, Géza Lakner et al.
2026-09-01 · DOI: 10.1093/jac/dkag317Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching-right-to-reply
Murat Özdede, Fatma Nisa Balli Turhan, Özgenur Geridönmez, Emre Kara et al.
2026-09-01 · DOI: 10.1093/jac/dkag288Reconciling differences between EUCAST ‘breakpoint-defining doses’ and UK national antimicrobial treatment guidelines
Conor Jamieson, Sara E Boyd, Mandy Wootton, David M Livermore et al.
2026-09-01 · DOI: 10.1093/jac/dkag315In silico resistance prediction of oral streptococci to recommended prophylactic antibiotics to prevent infective endocarditis upon dental procedures
Gabriela Ceccon Chianca, Raiane Cardoso Chamon, Julia Peixoto de Albuquerque, Helvécio Cardoso Corrêa Póvoa et al.
2026-09-01 · DOI: 10.1093/jac/dkag320The underappreciated role of rifampin in shaping the epidemiology of RT027-like Clostridioides difficile lineages
Isabella A Tickler, Richard V Goering, Fred C Tenover
2026-09-01 · DOI: 10.1093/jac/dkag310Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study
Norikazu Kitamura, Hirokazu Yano, Sayoko Kawakami, Sadao Aoki et al.
2026-09-01 · DOI: 10.1093/jac/dkag305HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy
Adam Abdullahi, Sophia Osawe, Haruna Wisso, Martin Edun et al.
2026-09-01 · DOI: 10.1093/jac/dkag300Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020–2021)
Flory Luzolo Khote, Hypolite Muhindo Mavoko, Patrick Mitashi, Papy Mandoko et al.
2026-09-01 · DOI: 10.1093/jac/dkag309Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial
M A M Ebrahim, M A M Nasr, M M M Abdel-Latif
2026-09-01 · DOI: 10.1093/jac/dkag318Reviews
Community Reviews
Version History
September 8, 2026 at 12:07 am
September 8, 2026